3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Classical hematology
1
Breast
1
Conditions
Multiple Myeloma
2
Lymphoma
2
Venous Thrombosis
1
Venous Thromboembolism
1
Vascular Diseases
1
Urogenital Neoplasms
1
Thromboembolism
1
Prostatic Neoplasms
1
Neoplasms
1
Myeloproliferative Disorders
1
Lymphoproliferative Disorders
1
Lymphatic Diseases
1
Lung Neoplasms
1
Leukemia
1
Intestinal Neoplasms
1
Hemostatic Disorders
1
Digestive System Neoplasms
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
75
fludarabine phosphate
73
Peripheral Blood Stem Cell Transplantation
59
Mycophenolic Acid
53
Tacrolimus
51
Whole-Body Irradiation
48
Busulfan
42
Antilymphocyte Serum
40
Cyclosporine
38
Filgrastim
32
fludarabine
31
Methotrexate
30
Melphalan
29
Radiotherapy
22
Methylprednisolone
18
Cord Blood Stem Cell Transplantation
17
Etoposide
16
Sirolimus
14
Alemtuzumab
13
Flow Cytometry
12
Cyclosporins
12
thymoglobulin
11
Granulocyte Colony-Stimulating Factor
11
Cytarabine
10
Psychiatric Rehabilitation
9
sargramostim
8
Thiotepa
8
Rituximab
8
Therapeutics
7
Stem Cell Transplantation
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
Tinzaparin
×
Lymphoid
×
Clear all
NCT03099031
2019-12-16
PREDICARE
LEO Pharma
Completed
420 enrolled